FDA, Creditors Oppose Drugmaker Humanigen's Ch. 11 Sale
Biopharmaceutical company Humanigen faced fire on multiple fronts Tuesday after it asked the Delaware bankruptcy court to approve a $2 million stalking horse credit bid from its debtor-in-possession lender, an entity...To view the full article, register now.
Already a subscriber? Click here to view full article